Cherokee Nation Sues J&J Over Risperdal Deception


Two years after Johnson & Johnson received a fine of $2.2 billion from the U.S. Department of Justice for “misbranding” Risperdal, the Cherokee Nation is suing the company for its misrepresentations of the drug as safe and effective for the elderly. J&J marketed Risperdal as a treatment for older people with agitation from dementia, a practice the FDA warned is dangerous for older people.

Article →

Of further interest:

Tribe Sues Over Drug ‘Misbranding’  (Sequoyah County Times)

Previous articleShould Physicians Read Journals? Given Current Standards, Maybe Not
Next articleTherapeutic Alliance can be Helpful or Harmful in Early Psychosis, Depending…
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].


  1. Umm, is this the same Johnson & Johnson as well as, subsidiary stated here:
    “By September 2012 Johnson & Johnson and Janssen Pharmaceuticals faced more than 130 Risperdal and/or Invega lawsuits”? The same Johnson & Johnson that had the $62 BILLION dollar settlement brought by the US Attorney General Eric Holder for the use of Invega Sustenna wrongly administered to/on our elderly? WOW.

    Report comment